14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
DGICB vs HIPO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over Hippo Holdings Inc. (HIPO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HIPO carries 47.0/100 (HOLD) at $37.92 (10.2x Forward P/E, 6.6% operating margin).
Composite vs. Pillar Nuance: While HIPO currently prints a higher short-term Unified Composite Score (47.0/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.6% operating margin) and revenue trajectory (-3.4% vs. +29.4% YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DGICB vs HIPO. Trailing 12-month operating profitability (DGICB 9.0% vs HIPO 6.6%) and valuation multiples (DGICB 14.4x vs HIPO 10.2x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Insurance - Property & Casualty value chain with $990.6M market capitalization and 6.6% operating margin.
OpEx & R&D Reinvestment51.8% of Rev ($281M)
90D Engineering Disclosures0 Published
Investor FAQ DGICB vs HIPO Key Questions & Quantitative Answers
As of Nov 16, 2026, DGICB (DGICB) is the stronger overall head-to-head candidate over Hippo Holdings Inc. (HIPO) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGICB carries a Unified Composite Score of 30.8/100 (SELL) at $28.55 (14.4x Forward P/E, 9.0% operating margin), whereas HIPO carries 47.0/100 (HOLD) at $37.92 (10.2x Forward P/E, 6.6% operating margin). Composite vs. Pillar Nuance: While HIPO currently prints a higher short-term Unified Composite Score (47.0/100 HOLD vs. DGICB 30.8/100 SELL), DGICB captures the overall institutional head-to-head verdict (6–4 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (9.0% vs. 6.6% operating margin) and revenue trajectory (-3.4% vs. +29.4% YoY).
DGICB leads the Growth & Scale pillar: DGICB posts -3.4% YoY revenue growth and -11.3% YoY earnings growth on $955M TTM revenue (9.2% gross margin, 9.0% operating margin), compared with HIPO at +29.4% YoY revenue growth and -91.2% YoY earnings growth on $543M TTM revenue (58.4% gross margin, 6.6% operating margin). On trailing 12-month operating scale, DGICB generates $955M in USD-normalized revenue versus $543M for HIPO. In operating R&D and SG&A reinvestment, DGICB deploys N/A (0 90-day corporate R&D disclosures) versus 51.8% of Rev ($281M) (0 disclosures) for HIPO.
DGICB screens cheaper on headline valuation multiples. DGICB trades at 14.4x Forward P/E, 15.2x Trailing P/E, 1.90x PEG, and 1.1x EV/Revenue (9.2% EBITDA margin), whereas HIPO trades at 10.2x Forward P/E, 30.2x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (21.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGICB (10.7% ROE) versus HIPO (7.2% ROE) capital efficiency.
In options market volatility and institutional positioning, DGICB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.27β · 86% Vol realized risk). By comparison, HIPO carries 67.7% implied volatility (7th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKOUT options structure phase (0.51β · 32% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.